VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 271, Issue 4 40-4, 1996, Pages

  Murck, H ^a   Guldner, J ^a   Colla Muller M ^a   Frieboes, R M ^a   Schier, T ^a   Wiedemann, K ^a   Holsboer, F ^a   Steiger, A ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

growth hormone; hypothalamic pituitary adrenocortical system; prolactin; sleep cycles; suprachiasmatic nucleus

Indexed keywords

GROWTH HORMONE; PROLACTIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CAT; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; RABBIT; REM SLEEP; SLEEP; SUPRACHIASMATIC NUCLEUS;

EID: 0029859028     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.271.4.r905     Document Type: Article

References (32)

1. Albers, H. E., S.-Y. Liou, E. G. Stopa, and R. T. Zoeller. Neurotransmitter colocalization and circadian rhythms. Prog Brain Res. 92: 289-307, 1992.
2. Begley, D. J. Peptides and the blood-brain barrier: the status of our understanding. Ann. NY Acad. Sci. 739: 89-100, 1994.
3. Besson, J., A. Sarrieau, M. Vial, J.-C. Marie, G. Rosselin, and W. Rostene. Characterization and autoradiographic distribution of vasoactive intestinal peptide binding sites in the rat central nervous system. Brain Res. 398: 329-336, 1986.
4. Bluet-Pajot, M.-T., F. Mounier, J.-F. Leonard, C. Kordon, and D. Durand. Vasoactive intestinal peptide induces a transient release of growth hormone in the rat. Peptides 8: 35-38, 1987.
5. Broadwell, R. D., and M. V. Sofroniew. Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system. Exp. Neurol. 120: 245-263, 1993.
6. Chee, C. A., B. Roozendaal, D. F. Swaab, E. Goudsmit, and M. Mirmiran. Vasoactive intestinal polypeptide neuron changes in the senile rat suprachiasmatic nucleus. Neurobiol. Aging 9: 307-312, 1988.
7. Czeisler, C. A., J. C. Zimmerman, J. M. Ronda, M. C. Moore-Ede, and E. D. Weitzman. Timing of REM sleep is coupled to the circadian rhythm of body temperature in man. Sleep 2: 329-346, 1980.
8. Drucker-Colin, R., J. Bernal-Pedraza, F. Fernandez-Cancino, and A. Oksenberg. Is vasoactive intestinal polypeptide (VIP) a sleep factor? Peptides 5: 837-840, 1984.
9. Frieboes, R.-M., H. Murck, P. Maier, T. Schier, F. Holsboer, and A. Steiger. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man. Neuroendocrinology 61: 584-589, 1995.
10. Friess, E., L. Trachsel, J. Guldner, T. Schier, A. Steiger, and F. Holsboer. DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am. J. Physiol. 268 (Endocrinol. Metab. 31): E107-E113, 1995.
11. Holsboer, F., U. von Bardeleben, and A. Steiger. Effects of intravenous cortcotropin-releasing hormone upon sleep-related growth hormone surge and sleep-EEG in man. Neuroendocrinology 48: 32-38, 1988.
12. Kato, Y., Y. Iwasaki, J. Iwasaki, H. Abe, N. Yanaihara, and H. Imura. Prolactin release by vasoactive intestinal polypeptide in rats. Endocrinology 103: 554-558, 1978.
13. Magistretti, P. J., P. Schönenberg, P. Kehrer, J.-L. Martin, and R. C. Gaillard. Actions of VIP, hGRF, PHI and secretin: comparative studies in cerebral cortex and adenohypophysis. Peptides 7, Suppl.: 175-180, 1986.
14. Mirmiran, M., J. Kruisbrink, N. P. A. Bos, D. Van der Werf, and G. J. Boer. Decrease of rapid eye movement sleep in the light by intraventricular application of a VIP-antagonist in the rat. Brain Res. 458: 192-194, 1988.
15. Mirmiran, M., D. F. Swaab, J. H. Kok, M. A. Hofman, W. Witting, and W. A. Van Gool. Circadian rhythms and the suprachiasmatic nucleus in perinatal development, aging and Alzheimer's disease. Prog. Brain Res. 93: 151-162, 1992.
16. Morin, A. J., L. Denoroy, and M. Jouvet. Daily variations in concentration of vasoactive intestinal peptide immunoreactivity in hypothalamic nuclei of rats rendered diurnal by restricted-schedule feeding. Neurosci. Lett. 152: 121-124, 1993.
17. Nicosia, S., A. Spada, C. Borghi, L. Cortelazzi, and G. Giannattasio. Effects of vasoactive intestinal polypeptide (VIP) in human prolactin (PRL) secreting pituitary adenomas. FEBS Lett. 112: 159-162, 1980.
18. Obál, F., Jr., P. Alföldi, A. B. Cady, L. Johannsen, G. Sary, and J. M. Krueger. Growth hormone-releasing factor enhances sleep in rats and rabbits. Am. J. Physiol. 255 (Regulatory Integrative Comp. Physiol. 24): R310-R316, 1988.
19. Obál, F., Jr., L. Payne, B. Kacsoh, M. Opp, L. Kapás, C. E. Grosvenor, and J. M. Krueger. Involvement of prolactin in the REM sleep-promoting activity of systemic vasoactive intestinal peptide (VIP). Brain Res. 645: 143-149, 1994.
20. Ottesen, B., A. N. Andersen, T. Gerstenberg, H. Ulrichsen, T. Manthorpe, and J. Fahrenkrug. VIP stimulates prolactin release in women. Lancet ii: 696, 1981.
21. Pacheco-Cano, M. T., F. García-Hernández, O. Prospéro-García, and R. Drucker-Colín. Vasoactive intestinal polypeptide induces REM recovery in insomniac forebrain lesioned cats. Sleep 13: 297-303, 1990.
22. Racagni, G., J. A. Apud, D. Cocchi, V. Locatelli, and E. E. Muller. GABAergic control of anterior pituitary hormone secretion. Life Sci. 31: 823-838, 1982.
23. Rechtschaffen, A., and A. Kales (Editors). A Manual of Standardized Terminology Techniques and Scoring System for Sleep Stages of Human Subjects. Bethesda, MD: US Dept. of Health, Education and Welfare, Neurological Information Network, 1968.
24. Riou, F., R. Cespuglio, and M. Jouvet. Endogenous peptides and sleep in the rat. III. The hypnogenic properties of vasoactive intestinal polypeptide. Neuropeptides 2: 265-277, 1982.
25. Robinson, M. L., and J. L. Fuchs. Vasoactive intestinal peptide binding in rodent suprachiasmatic nucleus: developmental and arcadian studies. Brain Res. 605: 271-279, 1993.
26. Rolandi, E., R. Franceschini, A. Cataldi, and T. Barreca. Twenty-four-hour secretory pattern of vasoactive intestinal polypeptide in the elderly. Gerontology 36: 356-360, 1990.
27. Shinohara, K., K. Tominaga, Y. Isobe, and S. T. Inouye. Photic regulation of peptides located in the ventrolateral subdivision of the suprachiasmatic nucleus of the rat: daily variations of vasoactive intestinal polypeptide, gastrin-releasing peptide, and neuropeptide Y. J. Neurosci. 13: 793-800, 1993.
28. Steiger, A., J. Guldner, U. Hemmeter, B. Rothe, K. Wiedemann, and F. Holsboer. Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 56: 566-573, 1992.
29. Steiger, A., J. Guldner, H. Knisatschek, B. Rothe, C. Lauer, and F. Holsboer. Effects of ACTH/MSH (4-9) analog (HOE 427) on the sleep EEG and nocturnal hormonal secretion in humans. Peptides 12: 1007-1010, 1991.
30. A-receptor modulation. Brain Res. 615: 267-274, 1993.
31. Van den Pol, A. N., and K. L. Tsujimoto. Neurotransmitters of the hypothalamic suprachiasmatic nucleus: immunocytochemical analysis of 25 neuronal antigens. Neuroscience 15: 1049-1086, 1985.
32. Wiedemann, K., U. von Bardeleben, and F. Holsboer. Influence of human corticotropin-releasing hormone and adrenocorticotropin upon spontaneous growth hormone secretion. Neuroendocrinology 54: 462-468, 1991.